![Ankita Kapoor Profile](https://pbs.twimg.com/profile_images/1412609178460372995/T7SZtG_L_x96.jpg)
Ankita Kapoor
@ankitakap
Followers
409
Following
1K
Statuses
280
Hematology/oncology fellow @RoswellPark via @rocregional & MAMC | 👦 Mom
Buffalo, NY
Joined July 2020
Excited to present our oral presentation at #ASH20 session 903 on Factors predictive of oral abstract being published: Is gender disparity playing a role? today at 9:45 PT. Thank you @ASH_hematology for this platform! @ROCRegional @SaadJamshedROC @ArjunKhunger @Nikhilheartdoc
5
5
25
Excellent discussion by @Deebacca, colorectal specialist on Early stage CRC!! @RoswellHemOnc @RoswellPark
0
5
22
RT @PTarantinoMD: Otto Metzger (@Otto_DFCI) presents the practice-changing results from the #PATINA phase 3 trial: adding palbociclib to ma…
0
62
0
RT @OncBrothers: #SABCS24 Day 2 Highlights #CommunityOnc: 1. #EMBER3: Oral SERD in HR+ 2. #OlympiA: PARPi in gBRCA 3. #Surgery in gBRCA…
0
25
0
RT @MeganKruseMD: Proud of @AzkaAliMD for representing @ClevelandClinic and @SWOG during today’s rapid fire oral session at #SABCS2024 with…
0
8
0
RT @royaryam: Important study from @matteolambe & colleagues at #SABCS2024! RRM & prophylactic oophorectomy improved survival outcomes in y…
0
5
0
@gandhi_shipra @royaryam @malaksalharbi1 Followed by interesting and well presented discussion by @DrHBurstein. @SABCSSanAntonio @OncBrothers @RoswellHemOnc @DanaFarber
0
0
3
RT @malaksalharbi1: What a refreshing start ahead of SABCS! We received invaluable advice from faculty. Key takeaway: our careers and goals…
0
5
0
RT @Sarbaji85064063: Amazing accomplishment by my star mentee @sawyer_bawek..three years in a row…looking forward to presenting our researc…
0
3
0
So proud of you!! 👏🏻👏🏻👏🏻
Thrilled to have my abstract selected as a Top 3 at @SALCS 2024 and to give my first oral presentation! Grateful for the incredible support from my mentor @RenukaIyer10 who helped make this possible. @RoswellHemOnc @RoswellPark @Jacobs_Med_UB
0
0
8
RT @OncBrothers: #Osimertinib now @US_FDA approved based off #LAURA: Ph III, Indefinite Osimertinib after ChemoXRT in Stage III mEGFR NSCLC…
0
43
0
RT @jayasreekris: Happy to share our multi-center study on real-world outcomes of Keynote 522. So thankful for the collaboration @LubnaChau…
0
7
0
RT @KibsTt: What began last year as a lemonade stand, raising $ for Wilmot, turned into a hotdog stand for this year. they raised $7,500 &…
0
2
0
RT @malaksalharbi1: Excited to share our new article proposing a dual strategy of chemokine modulation followed by checkpoint inhibitors as…
0
6
0
@waraonc23 @RoswellHemOnc @RoswellPark @yoshi735 @Rangermakok @DharmeshGopala1 @MSBI_IM @msmw_medchiefs Congratulations
1
0
2